Transaction · 0001437749-26-018628
ETONEton Pharmaceuticals, Inc.
Krempa David
Krempa David, CBO, reported a transaction classified as exercise at Eton Pharmaceuticals, Inc. involving 25000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
exerciseSEC transaction code MCBO
- Trade date
- May 26, 2026
- Filing date
- May 27, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ETON price since this filing
Daily closing prices, with the filing date and available return windowsETON · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -29.0%1w ago +1.5%1d ago +0.6%
Returns since7d -14.8%30d +10.2%90d +94.5%180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001437749-26-018628 Employee Stock Option
- Transaction date
- May 26, 2026 Filed May 27, 2026, 10:28 PM · 1d delay
- Shares
- 25,000 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 0 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership
Filing-only score
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
Mixed or weak signal
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
Chief Business Officer
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at…
- F2
The shares were sold in multiple trades at prices ranging from $33.68 to $34.66. The price reported above reflects the weighted average sales price.
- F3
The shares were sold in multiple trades at prices ranging from $31.27 to $32.16. The price reported above reflects the weighted average sales price.
- F4
The shares subject to the option vested in 48 equal monthly installments from the date of grant (3-12-2020) until fully vested.
- F5
The shares were sold in multiple trades at prices ranging from $31.25 to $31.825. The price reported above reflects the weighted average sales price.
- F6
The shares subject to the option vested annually from the date of grant (11-10-2017) in four equal installments.
- F7
The shares were sold in multiple trades at prices ranging from $32.67 to $33.65. The price reported above reflects the weighted average sales price.
- F8
The shares subject to option vested annually from the date of grant (8-7-2017) in four equal installments.
Related transactions
Same SEC filing0 other transactions
Recent company activity
ETON0 recent txs